Skip to content

Author

Guo-Qiang Pan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Breaking the Lipid Bottleneck: A Mitophagy-Driven Nanoregulator Amplifies Ferroptosis for Colorectal Cancer Immunotherapy.

Colorectal cancer (CRC) therapy is severely constrained by the immunosuppressive tumor microenvironment (TME). This study presents a TME-responsive nanometabolic regulator, ZnO2@Fe@HA (ZFH), designed to bridge mitochondrial dysfunction, lipid reprogramming, and ferroptosis to enhance anti-tumor immunity. ZFH specifical...

Shao-Peng Zhang, Guo-Qiang Pan, Qin-Nie Xu et al. · 0 citations
Open access Aug 2026

Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression

A novel interaction between hypoxia, glutamine metabolic reprogramming, and immune suppression in HCC progression is uncovered, positioning UBASH3B as a promising therapeutic target for overcoming hypoxia-induced treatment resistance.

Guo-Qiang Pan, Shaokai Zhang, Xi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.